AU2002210530A1 - Antisense nucleic acid against alphav integrin - Google Patents

Antisense nucleic acid against alphav integrin

Info

Publication number
AU2002210530A1
AU2002210530A1 AU2002210530A AU1053002A AU2002210530A1 AU 2002210530 A1 AU2002210530 A1 AU 2002210530A1 AU 2002210530 A AU2002210530 A AU 2002210530A AU 1053002 A AU1053002 A AU 1053002A AU 2002210530 A1 AU2002210530 A1 AU 2002210530A1
Authority
AU
Australia
Prior art keywords
nucleic acid
antisense nucleic
acid against
alphav integrin
alphav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210530A
Inventor
Thorsten Graf
Rainer Haas
Ralf Kronenwett
Wolfgang Nedbal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A3D GmbH
Original Assignee
A3D GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A3D GmbH filed Critical A3D GmbH
Publication of AU2002210530A1 publication Critical patent/AU2002210530A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
AU2002210530A 2000-10-12 2001-10-11 Antisense nucleic acid against alphav integrin Abandoned AU2002210530A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00121394A EP1197553A1 (en) 2000-10-12 2000-10-12 Antisense nucleic acid against alphaV integrin
EP00121394.1 2000-10-12
PCT/EP2001/011790 WO2002031142A2 (en) 2000-10-12 2001-10-11 Antisense nucleic acid against alphav integrin

Publications (1)

Publication Number Publication Date
AU2002210530A1 true AU2002210530A1 (en) 2002-04-22

Family

ID=8169980

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210530A Abandoned AU2002210530A1 (en) 2000-10-12 2001-10-11 Antisense nucleic acid against alphav integrin

Country Status (3)

Country Link
EP (2) EP1197553A1 (en)
AU (1) AU2002210530A1 (en)
WO (1) WO2002031142A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000877A2 (en) * 2000-06-29 2002-01-03 Mcgill University Antisense oligonucleotides to inhibit angiogenesis and/or metastasis
CN100537761C (en) * 2003-11-07 2009-09-09 中国人民解放军军事医学科学院放射医学研究所 Antisense oligonucleotide contains their drug regimen and is used for the treatment of the purposes of cancer
JP5637855B2 (en) 2007-11-08 2014-12-10 ザ ジェネラル ホスピタル コーポレイション Methods and compositions for the treatment of proteinuria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950097A2 (en) * 1996-12-27 1999-10-20 Instituto de Investigaciones Bioquimicas Fundacion Campomar Compositions and methods for tumour therapy
EP0950709A1 (en) * 1998-04-17 1999-10-20 Hoechst Marion Roussel Deutschland GmbH Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
WO2000044409A1 (en) * 1999-01-27 2000-08-03 University College London Formulations comprising antisense nucleotides to connexins

Also Published As

Publication number Publication date
EP1409668A2 (en) 2004-04-21
EP1197553A1 (en) 2002-04-17
WO2002031142A3 (en) 2003-01-09
WO2002031142A2 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2001273453A1 (en) Nucleic acid hairpin probes and uses thereof
AU2001210928A1 (en) Polypropylene card construction
AU2001293583A1 (en) Antisense iap nucleic acids and uses thereof
AU2001234741A1 (en) Integrin antagonists
EP1354950A4 (en) Nf-kb activating gene
AU5613401A (en) Four bar wiper-arm
GB0019745D0 (en) Gene expression element
AU2002245107A1 (en) Improved biochip
GB0007651D0 (en) Gene sequence
AU2001262974A1 (en) Dna alkylating agent and activation thereof
AU2003281867A1 (en) Antisense nucleic acids
AU2001294274A1 (en) Antibody inhibiting VPLF activity
PL352987A1 (en) Alphav
AU2001270478A1 (en) Gene expression in biological conditions
AU2002210530A1 (en) Antisense nucleic acid against alphav integrin
AU4225200A (en) Improved antisense oligomers
AU2002215389A1 (en) Optimized messenger rna
AU2001247444A1 (en) Erbeta-mediated gene expression
AUPQ749100A0 (en) New epilespy gene
AU2001288839A1 (en) Self-rearranging dna vectors
EP1165825A4 (en) Toxicant-induced differential gene expression
AU2001252390A1 (en) Nucleic acid immunization
PL352989A1 (en) Novel integrin alphav
AUPQ665000A0 (en) Improved catalyst
GB2362383B (en) Gene expression system